Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review

Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review

Cardiovascular diseases (CVD) are still the prevailing cause of death not only in industrialized countries, but even worldwide. Type 2 diabetes mellitus (type 2 DM) and hyperlipidemia, a metabolic disorder that is often associated with diabetes, are major risk factors for developing CVD. Recently, c...

Full description

Bibliographic Details
Main Authors: Srinivasan Vedantham, Anna-Kristina Kluever, Elisabeth Deindl
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Cells
Subjects:
cardiovascular disease (CVD)
arteriogenesis
diabetes mellitus
dipeptidyl-peptidase-4 (DPP4) inhibitors
stromal-cell-derived factor-1 (SDF-1)
gliptins
Online Access:http://www.mdpi.com/2073-4409/7/10/181

Internet

http://www.mdpi.com/2073-4409/7/10/181

Similar Items